C O M M U N I C A T I O N S
Figure 4. (A) Fluorescence changes of riboflavin (50 µM) and FMN (50
µM) with addition of 1 (excitation, 445 nm; emission, 525 nm); (B)
fluorescence changes of FAD (50 µM) with 2 (excitation, 445 nm; emission,
525 nm).
from among other flavins in water. The enhancement of fluores-
cence emission of FAD was caused by a change in the intramo-
lecular stacked conformation of FAD in water upon binding of the
phosphodiester group of FAD to 1. This probe was used to detect
FAD in eosinophils by fluorescence microscopy and FACS.
Figure 2. (A) Enhanced fluorescence of FAD (50 µM) upon addition of
1 (excitation, 445 nm; emission, 525 nm); (B) (left) increased FAD (10
µM) fluorescence upon addition of 2 equiv of 1; (right) only FAD
fluorescence (10 µM) under 365 nm UV lamp.
Acknowledgment. This work was supported by a grant from
the KRF (Grant No. KRF-2006-311-C00091). Partial support from
the Seoul R&BD is also acknowledged. H.-W. Rhee is the recipient
of the Seoul Science Fellowship.
Supporting Information Available: Synthesis and results sup-
porting the binding mode between 1 and FAD; complete procedures
of cell study and results with neutrophils. This material is available
References
(1) (a) Bruice, T. C. Acc. Chem. Res. 1980, 13, 256. (b) Ghisla, S.; Massey,
V. Eur. J. Biochem. 1989, 181, 1. (c) Fitzpatrick, P. F. Acc. Chem. Res.
2001, 34, 299. (d) Silverman, R. B. Acc. Chem. Res. 1995, 28, 335. (d)
Walsh, C. Acc. Chem. Res. 1980, 13, 148. (e) Massey, V. Biochem. Soc.
Trans. 2000, 28, 283.
(2) (a) Mayeno, A. N.; Hamann, K. J.; Gleich, G. J. J. Leukocyte Biol. 1992,
51, 172. (b) Weil, G. J.; Chused, T. M. Blood 1981, 57, 1099. (c) Monici,
M.; Pratesi, R.; Bernabei, P. A.; Caporale, R.; Ferrini, P. R.; Croce, A.
C.; Balzarini, P.; Bottiroli, G. J. Photochem. Photobiol. B 1995, 30, 29.
(3) Weber, G. Biochem. J. 1950, 47, 114.
(4) Britz-McKibbin, P.; Markuszewski, M. J.; Iyanagi, T.; Matsuda, K.;
Nishioka, T.; Terabe, S. Anal. Biochem. 2003, 313, 89.
Figure 3. (A) Natural autofluorescence of eosinophils before incubation
with 1; (B) enhanced autofluorescence of eosinophils after 15 min of
incubation with 1 (100 µM) in saline (150 mM NaCl, pH 7.4). The x-axis
in FACS shows the fluorescence intensity of each eosinophil cell and the
y-axis in FACS shows the eosinophil count. After incubation with 1, the
eosinophil distribution shifted to the stronger fluorescence intensity region.
The cells were fixed and permeabilized prior to addition of 1. Argon-ion
laser (488 nm) was used for fluorescence excitation of cell and 530 ((10)
nm emission filter was used in FACS. Scale bar ) 10 µm.
(5) (a) Yano, Y.; Tamura, N.; Mitsui, K.; Nabeshima, T. Chem. Lett. 1989,
1655. (b) Tamura, N.; Kajiki, T.; Nabeshima, T.; Yano, Y. J. Chem. Soc.
Chem. Commun. 1994, 2583 (c) Tamura, N.; Mitsui, K.; Nabeshima, T.;
Yano, Y. J. Chem. Soc., Perkin. Trans. 1994, 2, 2229.
(6) (a) Breinlinger, E.; Niemz, A.; Rotello, V. M. J. Am. Chem. Soc. 1995,
117, 5379. (b) Deans, R.; Cooke, G.; Rotello, V. M. J. Org. Chem. 1997,
62, 836. (c) Breinlinger, E. C.; Keenan, C. J.; Rotello, V. M. J. Am. Chem.
Soc. 1998, 120, 8606. (d) Boal, A. K.; Rotello, V. M. J. Am. Chem. Soc.
1999, 121, 4914.
eosinophils showed weak autofluorescence, and after incubation
with 1 its granules showed bright greenish fluorescence (Figure
3). The enhanced autofluorescence of eosinophils was also detected
by the fluorescence-activated cell sorter (FACS). The increased
autofluorescence of the eosinophils due to addition of 1 can be
used in the flow cytometry for eosinophil count;11 this is crucial to
immunological diagnosis for eosinophilia,11a an abnormal ac-
cumulation of eosinophils in blood or tissue, which occurs in certain
disease states. The control experiment using 2 showed almost no
enhancement of autofluorescence (see the SI). This is in good
agreement with little fluorescence change of FAD upon addition
of 2 as shown in Figure 4.
(7) Konig, B.; Pelka, M.; Zieg, H.; Ritter, T.; Bouas-Laurent, H.; Bonneau,
R.; Desvergne, J. P. J. Am. Chem. Soc. 1999, 121, 1681.
(8) Roychowdhury-Saha, M.; Lato, S. M.; Shank, E. D.; Burke, D. H.
Biochemistry 2002, 41, 2492.
(9) (a) Sarma, R. H.; Dannies, P.; Kaplan, N. O. Biochemistry, 1968, 7, 4359.
(b) Razka, M.; Kaplan, N. O. Proc. Natl. Acad. Sci. U.S.A. 1974, 71,
4546.
(10) (a) Ojida, A.; Inoue, M.; Mito-oka, Y.; Tsutsumi, H.; Sada, K.; Hamachi,
I. J. Am. Soc. Chem. 2006, 128, 2052. (b) Lee, D. H.; Im, J. H.; Son, S.
U.; Chung, Y. K.; Hong, J. I. J. Am. Soc. Chem. 2003, 125, 7752. (c)
Kruppa, M.; Konig, B. Chem. ReV. 2006, 106, 3520.
(11) (a) Rothenberg, M. E. N. Engl. J. Med. 1998, 338, 1592. (b) Weller, P. F.
N. Engl. J. Med. 1991, 324, 1110.
In summary, we have developed a novel fluorescent chemosensor
that uses the Zn2+-DPA complex, which selectively targets FAD
JA070026R
9
J. AM. CHEM. SOC. VOL. 129, NO. 15, 2007 4525